Dorothy Kamya

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

Nicholas I. Paton, Cissy Kityo, Immaculate Nankya et al. · The Lancet HIV · 2017 · 79 citations · Full text

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

James Hakim, Cissy Kityo, Anne Hoppé et al. · The Lancet Infectious Diseases · 2017 · 41 citations · Full text

Self-reported knowledge, attitudes, practices and barriers in use of evidence-based medicine among resident physicians in Kenya: a mixed methods study

Megha B. Unadkat, Caroline K. Mbuba, Anthony Ngugi et al. · BMC Medical Education · 2021 · 21 citations · Full text

Preconception Care among Pregnant Women in an Urban and a Rural Health Facility in Kenya: A Quantitative Study

Joan Okemo, Marleen Temmerman, Mukaindo Mwaniki et al. · International Journal of Environmental Research and Public Health · 2020 · 19 citations · Full text

Determinants of preconception care among pregnant women in an urban and a rural health facility in Kenya: a qualitative study

Joan Okemo, Dorothy Kamya, Abraham Mukaindo Mwaniki et al. · BMC Pregnancy and Childbirth · 2021 · 17 citations · Full text